In contrast, Mdm2 deficiency suppressed MYCN driven neuroblastoma tumorigenesis, as evident by an extended tumor latency and survival and reduced tumor incidence and growth in TH-MYCNMdm2 +/− transgenic mice compared with TH-MYCNMdm2 + / + mice. This evidence concerns the gene MYCN and neuroblastoma.